Illumina Inc

NASDAQ:ILMN   9:38:49 AM EDT
379.86
+0.38 (+0.10%)
Other Pre-Announcement, Mergers / Acquisitions

Illumina To Acquire Grail In $8 Billion Cash And Stock Deal

Published: 09/21/2020 11:19 GMT
Illumina Inc (ILMN) - Illumina to Acquire Grail to Launch New Era of Cancer Detection.
Illumina Inc - Deal for Cash and Stock Consideration of $8 Billion.
Illumina Inc - Grail Stockholders Will Receive Future Payments Representing a Tiered Single Digit Percentage of Certain Grail-related Revenues.
Illumina Inc - Illumina Currently Holds 14.5% of Grail's Shares Outstanding, and Approximately 12% on a Fully Diluted Basis.
Illumina Inc - Grail Stockholders Will Receive $3.5 Billion in Cash and $4.5 Billion in Shares of Illumina Common Stock.
Illumina Inc - Upon Closing of Transaction, Current Illumina Stockholders Are Expected to Own Approximately 93% of Combined Company.
Illumina Inc - in Connection With Transaction, Grail Stockholders Will Also Receive Contingent Value Rights.
Illumina Inc - Expect Transaction Will Be Accretive to Illumina Revenue Starting in 2021, and to Meaningfully Accelerate Revenue Growth Over Time.
Illumina Inc - Cash Consideration to Grail Stockholders Excluding Illumina of About $3.1 Billion to Be Funded Using Balance Sheet Cash of Both Cos.
Illumina - Cash Consideration to Grail Stockholders Excluding Illumina to Also Be Funded Using $1 Billion in Capital Raised Through Debt/equity Issuance.
Illumina Inc - Obtained Financing Commitments for a $1.0 Billion Bridge Facility With Goldman Sachs Bank USA.
Illumina Inc - Galleri to Launch Commercially in 2021 As a Multi-cancer, Laboratory Developed Test for Early Cancer Detection From Blood.